Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1839]
News [4199]
Articles [376]
Editorials [10]
Conferences [103]
elearning [29]
PARP inhibitory treatment for BRCA mutated and sporadic triple negative breast...
Dr Daniel Silver - Dana Farber Cancer Institute, Boston, Massachusetts, USA
PARP inhibitory treatment for BRCA mutated and sporadic triple negative breast cancer ( Dr Daniel Silver - Dana Farber Cancer Institute, Boston, Massachusetts, USA )
24 Nov 2011
Chemotherapy Foundation Symposium 2011
Prof Edward Ambinder - The Mount Sinai Hospital, New York, USA
Chemotherapy Foundation Symposium 2011 ( Prof Edward Ambinder - The Mount Sinai Hospital, New York, USA )
24 Nov 2011
New trastuzumab combinations for HER2 positive breast cancer
Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium
New trastuzumab combinations for HER2 positive breast cancer ( Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
24 Nov 2011
Importance of genetic profiling and a tribute to Dr Judah Folkman
Prof Norman Wolmark - Allegheny General Hospital, Pittsburgh, USA
Importance of genetic profiling and a tribute to Dr Judah Folkman ( Prof Norman Wolmark - Allegheny General Hospital, Pittsburgh, USA )
24 Nov 2011
Changes in breast cancer management
Prof David Cameron - Edinburgh Cancer Research Centre, UK
Changes in breast cancer management ( Prof David Cameron - Edinburgh Cancer Research Centre, UK )
11 Nov 2011
2011 St Gallen Consensus breast cancer recommendations
Prof Richard Gelber - Dana-Farber Cancer Institute, Boston, USA; Prof Aron...
2011 St Gallen Consensus breast cancer recommendations ( Prof Richard Gelber - Dana-Farber Cancer Institute, Boston, USA; Prof Aron Goldhirsch – European Institute of Oncology, Milan )
25 Oct 2011
Advances in the prevention of cervical cancer
Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Advances in the prevention of cervical cancer ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
21 Oct 2011
Use of circulating tumour cells as a prognostic or predictive marker
Prof Caroline Dive - Paterson Institute for Cancer Research, Manchester, UK
Use of circulating tumour cells as a prognostic or predictive marker ( Prof Caroline Dive - Paterson Institute for Cancer Research, Manchester, UK )
20 Oct 2011
Synchronous chemoradiation significantly reduces the risk of the breast cancer...
Dr Indrajit Fernando - Queen Elizabeth Hospital, Birmingham, UK
Synchronous chemoradiation significantly reduces the risk of the breast cancer recurrence ( Dr Indrajit Fernando - Queen Elizabeth Hospital, Birmingham, UK )
20 Oct 2011
Recent advances in advanced breast cancer
Prof Stephen Johnston; Prof Johanna Mattson; Prof Ahmad Awada; Prof Rob Coleman
Recent advances in advanced breast cancer ( Prof Stephen Johnston; Prof Johanna Mattson; Prof Ahmad Awada; Prof Rob Coleman )
18 Oct 2011
History and highlights of HBOC; understanding the genome and raising awareness
Prof Franco Muggia – New York University Medical Center, USA
History and highlights of HBOC; understanding the genome and raising awareness ( Prof Franco Muggia – New York University Medical Center, USA )
18 Oct 2011
Multi-centre male breast cancer study
Dr Laura Ottini – University of Rome La Sapienza, Italy
Multi-centre male breast cancer study ( Dr Laura Ottini – University of Rome La Sapienza, Italy )
18 Oct 2011

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation